NewsWhore
04-20-2012, 02:40 PM
LONDON (Reuters) - European regulators on Friday backed approval of a new diabetes drug from AstraZeneca and Bristol-Myers Squibb that was rejected last year in the United ...
More... (http://story.argentinastar.com/index.php/ct/9/cid/d9ed072d737073b4/id/205098583/)
More... (http://story.argentinastar.com/index.php/ct/9/cid/d9ed072d737073b4/id/205098583/)